Nanobiomedicine, cancer immunotherapy, and autoimmune diseases

The overall objective of our group is to understand nanomedicines-mediated molecular and cellular mechanisms in distinct biomedical applications oriented to cancer and autoimmunity treatment, and to use this knowledge to improve nanomedicines functional design for antitumour and autoinmune disease therapies.